JDS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Dairy Science Vol. 82 No. 6 1108-1114
© 1999 by American Dairy Science Association ®
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perdigón, G.
Right arrow Articles by Medici, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perdigón, G.
Right arrow Articles by Medici, M.

Study of the Possible Mechanisms Involved in the Mucosal Immune System Activation by Lactic Acid Bacteria

G. Perdigón 1, E. Vintiñ 2, S. Alvarez 1, M. Medina 3, and M. Medici 3

1 Centro de Referencias para Lactobacilos (CERELA), Chacabuco 145, 4000, Tucumán, Argentina, Ca' tedra de Inmunología, Instituto de Microbiología, Facultad de Bioquímica, Química y Farmacia, Universidad Nacional de Tucumaán
2 Ca' tedra de Inmunología, Instituto de Microbiología, Facultad de Bioquímica, Química y Farmacia, Universidad Nacional de Tucumaán
3 Centro de Referencias para Lactobacilos (CERELA), Chacabuco 145, 4000, Tucumán, Argentina

The induction of a mucosal immune response is not easy due to the development of oral tolerance, but under some conditions, bacteria can activate this immune system. Antigens administered orally can interact with M cells of Peyer's patches or bind to the epithelial cells. We have demonstrated that certain lactic acid bacteria are able to induce specific secretory immunity, and others will enhance the gut inflammatory immune response. The aim of this work was to establish the reason for these different behaviors and to define possible mechanisms involved in the interaction of lactic acid bacteria at the intestinal level. We studied IgA+ and IgM+ B cells comparatively in bronchus and intestine and CD4+ T cells and IgA anti-lactic acid bacteria antibodies in the intestinal fluid, induced by oral administration of Lactobacillus casei, Lb. delbrueckii ssp. bulgaricus, Lb. acidophilus, Lb. plantarum, Lb. rhamnosus, Lactococcus lactis, and Streptococcus salivarius ssp. thermophilus. The increase in the IgA+ B cells in the bronchus means that these lactic acid bacteria were able to induce the IgA cycle by interaction with M cells from Peyer's patches or intestinal epithelial cells. The IgM+ cells increased when the stimulus did not induce the switch from IgM+ to IgA+. The increase in the CD4+ cells suggests interaction of Peyer's patches and enhancement of the B- and T-cell migration. The anti-lactic acid bacteria antibody is related to the processing and presentation of the microorganisms to the immune cells. We demonstrated that Lb. casei and Lb. plantarum were able to interact with Peyer's patch cells and showed an increase in IgA+, CD4+ cells, and antibodies specific for the stimulating strain. Lactobacillus acidophilus induced gut mucosal activation by interaction with the epithelial cells without increase in the immune cells associated with the bronchus. Although Lb. rhamnosus and Strep. salivarius ssp. thermophilus interact with epithelial cells, they also induced an immune response against their epitopes. Lactococcus lactis and Lb. delbrueckii ssp. bulgaricus induced an increase of IgA+ cells entering the IgA cycle but not CD4+ cells; thus, these bacteria would have been bound to epithelial cells that activated B lymphocytes without processing and presenting of their epitopes. We did not determine specific antibodies against Lc. lactis or Lb. bulgaricus.

Key Words: lactic acid bacteria • intestinal interactions • immunomodulation

Submitted on September 28, 1998
Accepted on January 11, 1999




This article has been cited by other articles:


Home page
J DAIRY SCIHome page
A. de Moreno de LeBlanc, C. Matar, E. Farnworth, and G. Perdigon
Study of Immune Cells Involved in the Antitumor Effect of Kefir in a Murine Breast Cancer Model
J Dairy Sci, April 1, 2007; 90(4): 1920 - 1928.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. Matsuzaki, A. Takagi, H. Ikemura, T. Matsuguchi, and T. Yokokura
Intestinal Microflora: Probiotics and Autoimmunity
J. Nutr., March 1, 2007; 137(3): 798S - 802S.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
K. A. Aires, A. M. Cianciarullo, S. M. Carneiro, L. L. Villa, E. Boccardo, G. Perez-Martinez, I. Perez-Arellano, M. L. S. Oliveira, and P. L. Ho
Production of Human Papillomavirus Type 16 L1 Virus-Like Particles by Recombinant Lactobacillus casei Cells
Appl. Envir. Microbiol., January 1, 2006; 72(1): 745 - 752.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
I. Ingrassia, A. Leplingard, and A. Darfeuille-Michaud
Lactobacillus casei DN-114 001 Inhibits the Ability of Adherent-Invasive Escherichia coli Isolated from Crohn's Disease Patients To Adhere to and To Invade Intestinal Epithelial Cells
Appl. Envir. Microbiol., June 1, 2005; 71(6): 2880 - 2887.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Villena, S. Racedo, G. Aguero, E. Bru, M. Medina, and S. Alvarez
Lactobacillus casei Improves Resistance to Pneumococcal Respiratory Infection in Malnourished Mice
J. Nutr., June 1, 2005; 135(6): 1462 - 1469.
[Abstract] [Full Text] [PDF]


Home page
The Journal of the Royal Society for the Promotion of HealthHome page
S. Rodgers
Technological developments and the need for technical competencies in food services
The Journal of the Royal Society for the Promotion of Health, May 1, 2005; 125(3): 117 - 123.
[Abstract] [PDF]


Home page
Appl. Environ. Microbiol.Home page
R. Oozeer, D. D. G. Mater, N. Goupil-Feuillerat, and G. Corthier
Initiation of Protein Synthesis by a Labeled Derivative of the Lactobacillus casei DN-114 001 Strain during Transit from the Stomach to the Cecum in Mice Harboring Human Microbiota
Appl. Envir. Microbiol., December 1, 2004; 70(12): 6992 - 6997.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
J. LeBlanc, I. Fliss, and C. Matar
Induction of a Humoral Immune Response following an Escherichia coli O157:H7 Infection with an Immunomodulatory Peptidic Fraction Derived from Lactobacillus helveticus-Fermented Milk
Clin. Vaccine Immunol., November 1, 2004; 11(6): 1171 - 1181.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A D G Anderson, C E McNaught, P K Jain, and J MacFie
Randomised clinical trial of synbiotic therapy in elective surgical patients
Gut, February 1, 2004; 53(2): 241 - 245.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
J. G. LeBlanc, C. Matar, J. C. Valdez, J. LeBlanc, and G. Perdigon
Immunomodulating Effects of Peptidic Fractions Issued from Milk Fermented with Lactobacillus helveticus
J Dairy Sci, November 1, 2002; 85(11): 2733 - 2742.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
R. Oozeer, N. Goupil-Feuillerat, C. A. Alpert, M. van de Guchte, J. Anba, J. Mengaud, and G. Corthier
Lactobacillus casei Is Able To Survive and Initiate Protein Synthesis during Its Transit in the Digestive Tract of Human Flora-Associated Mice
Appl. Envir. Microbiol., July 1, 2002; 68(7): 3570 - 3574.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Dairy Science Association ®.